ONCO Onconetix: Enterprise Value-to-Revenue Multiple

Official company branding of onconetix.gcs-web.com (ONCO)

Onconetix, Inc. (ONCO) integrates telemedicine and biotechnology to combat prostate cancer, which defines its payout trajectory. The enterprise value-to-revenue ratio serves as a confidence indicator, with the current figure standing at 63911.11. A virtual development model utilizing outsourced manufacturing reduces costs, while optimized raw material supply chains eliminate any procurement disruptions.

ONCO: Onconetix EV/Sales Multiple 11/23/2025 - 11/20/2026

Onconetix Corporation - analytical breakdowns and key metrics (ONCO)

- market value and analyst target forecast:
Fundamental valuation:Onconetix, ONCO
Manufactured products of Onconetix Corp

Onconetix, Inc. (ONCO) suffers from weak operational capacity within the men's health segment, which limits the generation of sustainable cash flows and creates risks for its capitalization. The EV/Sales metric quantifies this by comparing Enterprise Value to revenue regardless of debt load, allowing for an assessment of the actual market premium paid for the company's fragile assets relative to its business value.

Direct competitors

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|TRIB: EV/Sales Multiple|ProPhase - Business Value to Revenue|Enterprise Value-to-Revenue Ratio ainos.com|CODX: Business Value to Revenue|Enterprise Value-to-Revenue Ratio HeartSciences (HSCS)|Company Value to Revenue Biomerica Inc. BMRA|EV/Sales Multiple CDIO (Cardio Diagnostics)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue